03.08.23 -- Walgreens Exec: "Optionality" Is The Way Forward For Hybrid Trials

How does the cell and gene therapy supply chain team stay ahead of the expected changes and respond at the speed the developing program expects? Supplier selection, raw materials, built-in quality, warehousing and logistics, and traceability are all covered in this article.

When it comes to decentralized clinical trials, explore why sponsors and research sites might need to look more closely at their specific patient cohorts when determining what individuals they truly need.

Emerging biotech companies now face multiple hurdles — from compressed timelines and choosing the right biomarkers, to transparency throughout the investigational new drug application. Gain insight into tackling these potential challenges during the clinical trial process.

The prognosis for the possibility of a recession — and what kind of impact it might have on life sciences companies — offers reasons to be cautious, and also to be hopeful.

The OCT Clinical team is very particular about its approach to delivering seamless clinical trial conduct. Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.

The vice president of oncology at Philips Pharma Solutions (formerly BioTel Research), Dr. Ed Ashton, addresses the many different facets of oncology imaging techniques in clinical trials. 

Walgreens head of decentralized clinical trials, John Campbell, believes clinical trials will one day allow patients to choose when and where they will participate in a clinical trial. Campbell contends true patient centricity would allow patients to pick whether they’re seen at home, at a site, at a pharmacy, or any combination of locations.

To create an effective DCT, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.

Accelerated by pandemic restrictions, discover how the shift to decentralized or hybrid clinical trials is expanding the scope of drug development at multiple levels.